Introduction
Immune responses to antigens are distinguished by a distinct pattern of cytokines produced by subsets of CD4 + T helper (Th) cells that result in cell-mediated or humoral immunity. Th1 cells produce IL-2, IFN-␥ and TNF-␣ and promote delayed-type hypersensitivity reactions while Th2 cells produce IL-4, IL-5, IL-6, IL-10 and IL-13 but not IL-2 or IFN-␥ and promote allergic-type responses, 1,2 by stimulating B cells, mast cells and eosinophils. 3 Differentiation of naive T cells into cells of the Th2 phenotype requires the presence of IL-4. [4] [5] [6] IL-4 also suppresses development of IL-2 and IFN-␥ secreting effector cells. 4 Even low levels of IL-4 are effective since blocking the effects of IL-4 by adding neutralizing monoclonal antibodies has a dramatic effect even if the levels of IL-4 in the supernatants of the cultures are low or undetectable. 4, 7 Several recent reports have confirmed the beneficial effects of the absence of IL-4 on colitis in different models of inflammatory bowel disease (IBD). [8] [9] [10] [11] [12] Dextran sulphate sodium (DSS) given via drinking water can induce a form of colitis in mice with features similar to those found in human ulcerative colitis. Our previous findings have confirmed that colitis is limited to the large intestine and is more prominent in the distal colon and rectum. 13 In our hands, inflammatory changes were diffuse and were restricted/most prominent in the mucosa. Initially, an inflammatory infiltrate consisting of macrophages, neutrophils and eosinophils appears, cryptitis and crypt abscesses follow and finally erosions and broad-based mucosal ulceration develop. 13, 14 Cyclic ingestion of DSS leads to chronic colitis characterized by lymphocyte infiltration and distortion of crypt architecture while prolonged exposure leads to hyperplasia and dysplasia. [15] [16] [17] In this study DSS-induced experimental colitis was induced in IL-4 deficient mice and the outcome of the inflammation examined and compared to the IL-4+/+ mice. Interleukin 4-deficient mice have normal B and T cell development, low serum levels of IgG1 and undetectable IgE, 18 impaired peripheral eosinophilia and their cells produce less IL-5, IL-9 and IL-10. 19 They are characterized by an increase in IFN␥ production and an overall Th1 type environment in the tissues.
Results

Activity of the disease is lower in IL-4 deficient than in the IL-4 positive mice
The activity of the disease was assessed in six consecutive experiments in which colitis was induced by ingestion of either 2.5% or 5% DSS in the drinking water. IL-4+/+ littermates were used as a control group. In every one of the experiments the severity of the disease was much lower in the IL-4 deficient mice than in the control group. Shortly, IL-4 deficient mice lost less weight and even though they also developed diarrhea, gross rectal bleeding and severe weight loss was rarely seen. Bloody diarrhea was seen in 32.5% (13/40) of IL-4−/− and in 74.5% (29/39) of the IL-4+/+ mice in which colitis was induced by 5% DSS. To demonstrate the delay in appearance of clinical signs, disease activity index (DAI) was calculated on a daily basis in the first two experiments (Figure 1a,b) . The difference was statistically significant starting from day 3 in the 2.5% DSS (P = 0.02) and from day 2 in the 5% DSS (P = 0.0001).
As established by histopathological examination, inflammation in IL-4 deficient mice was ameliorated when compared to the control group (Figure 2 ). Both mononuclear cell infiltrate and neutrophils infiltrate was reduced in IL-4 deficient mice. Ulceration, when present, was smaller and rarely extended through the whole transverse section (Figure 3a) . Mice from the control group, on the other hand, had extensive infiltration with mononuclear cells and neutrophils in the colon, severe ulceration and often complete denudation of the epithelial layer (Figure 3b ). Histopathological scoring of samples revealed consistently lower scores in the IL-4 deficient group than in the control group (Figure 2) . However, when histological scores were analyzed by Mann-Whitney U test for non-parametric data, P values were close but not below 0.05 that was considered to be a significance level. The reason for that could be that the histological scoring system that we used did not account for the extent of the damage but rather for the presence or absence of it.
Immunoglobulin production in colons of healthy IL-4 deficient mice
The intestinal tract is a single, most important source of immunoglobulin production 20, 21 and immunoglobulins produced by intestinal plasma cells play an important role in preventing intestinal injuries caused by enteric pathogens. As IL-4 plays a significant role in immunoglobulin production and isotype switching, immunoglobulin levels were first assessed in sera of healthy IL-4 deficient mice and the control littermates. Our findings in the sera were very similar to what was initially described by Kuhn et al, 18 ie while IgG1 was almost absent in IL-4 deficient mice, levels of other IgG isotypes were similar to what was found in the IL-4+/+ littermates ( Table 1) . Numbers of IgG1-producing cells in the colons of these mice were similar to the control strain but there was a two-fold higher number of IgG2-subclassesproducing cells in IL-4 deficient mice (Figure 4b) .
Because of the importance of IgA in mucosal protection and the postulated role that IL-4 may play in immunoglobulin switching from IgM to IgA, numbers of IgA and IgM-producing cells in colonic mucosa was also assessed and was similar in IL-4 deficient mice and in the IL-4+/+ littermates ( Figure 4a ).
Immunoglobulin production in IL-4 deficient mice after induction of colitis
Numbers of IgA and IgM-producing cells decreased during the course of the colitis. IgA-producing cells decreased to a lesser extent in the IL-4 deficient mice, so that their numbers were two-fold higher in the inflamed colons after 6 days of DSS ingestion (Figure 5a ). There As shown by ELISA, IgG1 levels were significantly lower to absent in IL-4 deficient mice. IgG2b levels rose significantly during the course of the disease but were not different in the IL-4 deficient mice when compared to the wild-type.
were fewer and similar numbers of IgM-producing cells in the inflamed colons of both mice strains ( Figure 5a ). Induction of colitis resulted in a two-fold increase of all IgG subtypes in IL-4 deficient mice. There was fourfold more IgG-producing cells in the inflamed colon of the IL-4+/+ strain, so, when the two strains were compared, no significant difference could be seen (Figure 5b ).
IgG2b was the dominant immunoglobulin that increased in sera collected after 6 days of DSS exposure in both mouse strains (Table 1) .
IL-10 mRNA in colonic tissues
It has previously been shown by others that IL-10 is an important cytokine that has the capacity to modify the extent of colonic damage in several models of colitis. 22, 23 Similarly, it was found that IL-10 levels in DSS-induced colitis increase 24, 25 and that treatment with IL-10 ameliorates the colitis while blocking endogenous IL-10 exacerbates it. 24 Thus, the importance of looking into IL-10 expression in inflamed colonic tissue.
We did not attempt to quantify IL-10 mRNA expression. However, in situ hybridization was done to assess if IL-10 is expressed in colonic tissues of IL-4
Figure 5
Immunoglobulin-producing cells in inflamed colons. While numbers of IgA-producing cells change only slightly with induction of inflammation in IL-4 deficient mice, it decreased significantly in the IL-4+/+ littermates. Numbers of IgG-producing cells increased in both strains and were similar in the inflamed colons 6 days after 5% DSS ingestion. Findings were similar when colitis was induced with 2.5% DSS (data not shown). deficient mice. We were able to demonstrate that cells containing mRNA for IL-10 were present in the inflamed colonic tissue ( Figure 6 ). Many of the IL-10-producing cells were aggregated in the submucosa and the lymphoid follicles of lamina propria mucosae. IL-10-producing cells could also be seen between crypts in the lamina propria.
It did not appear that there was a difference in the expression between the IL-4 deficient mice and the control strain but actual quantification of the cells was not attempted. 
IFN␥ contents in colonic tissues was higher in the IL-4 deficient mice regardless of the concentration of DSS used to induce the colitis
Care was taken to standardize the assay for assessing IFN␥ contents in the tissues by taking samples of colonic tissue from the same location in each animal at 2 cm proximal to the termination of rectum. IFN␥ content in the inflamed colons was always higher in the IL-4 deficient mice regardless of the concentration of DSS used to induce the colitis (Figure 7 ). 
Discussion
Ingestion of DSS given in the drinking water in mice causes colitis that closely resembles IBD. The pathogenetic events leading to colonic inflammation remain largely unknown. In this study, we looked at the effects of IL-4 on the development and severity of the disease.
The results described were somewhat surprising and suggest that IL-4 directly or via its effects on other proinflammatory mediators modifies the mechanisms of inflammation in this model of colitis. In addition, a recent study in this model of colitis has shown only a modest increase in IL-4 mRNA that increased if higher concentration of DSS was used. 25 There was a clear difference in the severity of the disease as determined by both clinical and histopathological features. IL-4 deficient mice lost less weight during the course of the colitis and the other clinical signs (diarrhea and rectal bleeding) developed at a later stage of the disease. The inflammatory infiltrate and ulceration, when present, was much less extensive in the IL-4 deficient mice; it never extended throughout the entire transverse section.
In this study, for the first time, we examined changes in immunoglobulin production during DSS-induced colitis. As it appears, there is a loss of IgA-producing cells in the inflamed colonic mucosa. At the same time, colitis is characterized with an increase of IgG2 immunoglobulins. In inflamed colonic tissues, there is an increase of all of the IgG2 immunoglobulin-producing cells.
Assessment of IgG subclass levels in mice sera showed that there was a three-fold increase in IgG2b levels during the course of the colitis. The capacity of DSS to induce polyclonal expansion of B cells and to generate production of predominantly IgG2b and IgG3 immunoglobulins has been reported previously in vitro. 26 Therefore, the preferential increase in serum IgG2b during the course of the colitis may be due to the direct effect of DSS on B cells.
IL-4 has a well known array of effects on B cell proliferation and immunoglobulin production and isotype switching. IL-4 deficient mice had a lower number of IgM-producing-cells and similar numbers of IgA-producing cells indicating that there is no obligatory role for IL-4 in isotype switching from IgM to IgA. While numbers of IgA-producing cells decreased significantly during the course of the colitis in the wild-type mice, in the IL-4 deficient mice they remained steady. It is unclear however, whether this effect is a cause or the consequence of the ameliorated disease process in the colon.
One of the main activities of IL-4 is to act as a switch factor for IgG1. 27 Consequently, IL-4 deficient mice have been described as having low levels of IgG1. 18 Despite significantly lower levels of IgG1 in the serum, the numbers of IgG1-producing cells in the colonic tissue were similar in both mice strains and did not change significantly during the course of the colitis. Numbers of IgG2a, IgG2b and IgG3-producing cells before the colitis was induced were two-fold higher in the IL-4 deficient mice. The higher numbers of IgG2a, IgG2b and IgG3-producing cells in IL-4 deficient mice colonic mucosa before colitis was induced may have had a beneficial effect sufficient to ameliorate the disease process.
IL-4 has a profound effect on the ability of T cells to differentiate into Th1 or Th2 type helper cells. IL-4 deficient mice lack Th2 type cytokines such as IL-5 and
Genes and Immunity IL-10. 19 Our previous studies showed that IL-5 does not influence the severity of the inflammation in this model of colitis. 28 In regard to IL-10, several studies have demonstrated that IL-10 has a beneficial effect in IBD. 22, 23 IL-10 deficient mice bred in a normal environment as opposed to a germ-free state develop IBD that is ameliorated by the administration of IL-10. 22 Similar results were achieved by treating mice with trinitrobenzenesulphonic acid (TNBS)-induced colitis with IL-10. 23 Treatment using IL-10 restored tolerance to bacterial sonicates indicating an important role for IL-10 in regulating tolerance towards intestinal flora and opening exciting possibilities of using IL-10 to treat patients with IBD.
It was shown by others that IL-10 levels in DSSinduced colitis increase. 24 In chronic DSS-induced colitis, treatment with IL-10 ameliorated the intestinal inflammation while blocking endogenous IL-10 caused exacerbation of the inflammation. 24 We assessed IL-10 mRNA expression by in situ hybridization and determined that IL-10 was expressed in the inflamed tissues of IL-4 deficient mice and that there was no difference in the levels of expression of IL-10 between the IL-4 deficient mice and the IL-4+/+ strain.
Our results that show higher levels of IFN␥ in the inflamed colonic tissue of IL-4 deficient mice are in agreement with previous reports of the role of IL-4 has in T cell differentiation. It has been shown that chronic DSSinduced colitis is characterized by both Th1-and Th2-type response. 29 Recent studies in chronic DSS-induced colitis have shown that IFN␥ increases with development of lesions and that treatment with neutralizing antibodies to IFN␥ reduces histological scores. 30 In another study, in which DSS colitis was induced in CCR5 and CCR2-deficient mice, IFN␥ has been implicated as a possible contributing factor to tissue damage. 31 The results of this study indicate that, in the acute phase of DSS colitis, IFN␥ may not be a crucial mediator of tissue damage or that its expression levels do not correlate with the histological score at this stage of the colitis.
Materials and methods
Mice IL-4 deficient mice used for induction of colitis were of 129SV × C57Bl/6 background and were kindly provided by Manfred Kopf, Basel Institute of Immunology, Basel, Switzerland.
19 IL-4+/+ littermates were used as a control group. Functional disruption of the IL-4 gene has been regularly confirmed both by the absence of IL-4 mRNA as measured by RT-PCR and by the absence of bioactivity (as determined by the failure of the IL-4 sensitive cell line, 4S, to proliferate in response to supernatants from anti-CD3 plus IL-2 stimulated IL-4−/− CD4 + T cells). Mice were housed under standard laboratory conditions according to the Australian National University guidelines and were fed sterile food and water ad libitum. Females (total number 55 for 2.5% DSS-induced colitis and 60 for 5% DSS-induced colitis) in a total number of six experiments were used. The studies were approved by The Animal Experimentation Ethics Committee of The Australian National University.
Dextran sulphate sodium
The DSS used was a sodium salt of molecular weight of 41 K and with sulphur substitution of 16.3 (TdB Consultancy, Uppsala, Sweden). DSS was given as 2.5% and 5% solutions in distilled water for 8 days.
Disease activity index (DAI)
DAI was derived from the three major clinical signs (weight loss, diarrhea and rectal bleeding) as previously described. 13 The clinical signs were analyzed separately and correlated with the histological score. The final formula for the DAI was evaluated by correlation with the histological score as previously described. 13 The DAI was defined as: DAI = (weight loss) + (diarrhea score) + (rectal bleeding score).
Body weight loss: Body weight loss was calculated as the difference between the predicted body weight and the actual body weight on a particular day. The formula for predicted body weight was derived by simple regression using the body weight data for the control group. The following formula was derived: Y = a + kx, where Y = body weight change (loss or gain), k = daily increase in body weight, x = day, a = starting body weight. The daily increase in body weight (k) was 0.251 for the IL-4+/+ strain and 0.242 for the IL-4 deficient mouse strain.
Diarrhea:
The appearance of diarrhea was defined as mucus/fecal material adherent to anal fur. The presence or absence of diarrhea was scored as either 1 or 0 respectively. The cumulative score for diarrhea was calculated by adding the score for each day and dividing this number by the number of days of exposure.
Rectal bleeding: The appearance of rectal bleeding was defined as diarrhea containing blood or mucus or frank rectal bleeding. The final score for rectal bleeding was calculated as described for diarrhea.
Histopathological examination and scoring
Tissue specimens were fixed in 10% neutral formalin and embedded in paraffin. Colons were divided into right, transverse and left and specimens stained with haematoxylin and eosin. Histological examination was performed on serial sections. Three serial sections of five to six different sites of the colon (accounting for up to 18 sections per mouse) were examined and the most affected part scored blindly using a standard 12-point histological scoring system.
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Immunofluorescent staining
The specimens were fixed using cold ethanol, 33 embedded in paraffin and 5-sections cut on to gelatin-coated slides. Immunoglobulin-producing cells were detected by immunofluorescence as previously described. 34 Briefly, tissues were dewaxed, rehydrated and then incubated with goat anti-mouse IgA (alpha heavy chain specific) (Seralab, Crawley Down, Sussex, UK), 1/60; fluoresceinconjugated rabbit affinity-purified antibody to mouse IgG1 (Cappel-Organon Teknika Corporation, Durham, NC, USA) used in dilution, 1/100; fluorescein-conjugated rabbit affinity-purified antibody to mouse IgG2a (CappelOrganon Teknika Corporation), 1/25; fluorescein-conjugated rabbit affinity-purified antibody to mouse IgG2b (Cappel-Organon Teknika Corporation) used at dilution, 1/25 and fluorescein-conjugated rabbit affinity-purified antibody to mouse IgG3 (Cappel-Organon Teknika Corporation), 1/40. Anti-goat immunoglobulin TRITC conjugated (ATAB Atlantic Antibodies) was used at a dilution of 1/100 as a secondary antibody.
Following each 20-min incubation, excess reagent was removed and the slides rinsed in phosphate-buffered saline (PBS). Finally slides were rinsed for 1 h in PBS and mounted using 90% glycerol in PBS. The number of Igcontaining cells in the intestine were counted using a 40× objective and 10× eyepieces using a Zeiss Axioskop 20 microscope with incident light illumination. Each section of the intestine was scanned from the tips of the villi to the base of the mucosa, and cells were counted in a total of 30 such scans. The average number of cells per scan was expressed as cells per linear cm of intestine by multiplying by 30.3, a correction factor determined from the field width of 330 m, as previously described.
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Enzyme-linked immunoabsorbent assay (ELISA) for detection of immunoglobulin levels in the serum Activated polyvinyl chloride immuno-assay plates were coated with 1:2000 dilution of goat anti-mouse IgG (H+E) (Caltag Immunodiagnostics, Burlingame, USA) in carbonate buffer for detection of immunoglobulin subtypes in the serum and with 1:5000 dilution of goat anti-mouse unlabelled antibodies in carbonate buffer as a standard. Plates were stored overnight at 4°C, were washed five times with PBS in 0.04% Tween 20. Skim milk powder (4% in PBS, 100 l per well) (Carnation, Australia) was used for blocking for 1 h at 37°C. After washing the plates five times with PBS in 0.04% Tween 20, two-fold serial dilutions of the samples were performed starting from 1:1000, added at 50 l per well and the wells were incubated at 37°C for 2 h. Goat anti-mouse biotinylated antibodies were diluted in PBS in 0.04% Tween 20 at 1:2000 for IgG1, 1:500 for IgG2a and 1:250 for IgG2b and were added to the plates at 50 l per well for 1 h. After washing with PBS in 0.04% Tween 20 five times, streptavidin alkaline phosphatase (Amersham International, Buckinghamshire, UK) 1:1000 in PBS was added at 50 l per well and the plates were incubated for 1 h. Plates were washed with PBS in 0.04% Tween 20, five times and substrate solution was added at 50 l per well. Absorbance was read at 405-490 nm. Samples were blinded for determination of immunoglobulin levels.
In situ hybridization for mouse IL-10
In situ hybridization was carried out according to the method described by Pyke et al. 36 IL-4+/+ and IL-4−/− mice were exposed to 2.5% and 5% DSS for 8 days. Colons were removed, washed in normal saline and then fixed in periodate-lysine-paraformaldehyde fixative for 3 h. Prior to embedding, tissue was transferred to 20% sucrose for 3-4 h and to 7% sucrose overnight. Tissues were embedded in paraffin. 3-sections were cut on gelatin-coated, RNAase-free slides, under RNAase-free conditions and were heated to 60°C for 60 min.
Pre-hybridization treatment of tissue: Paraffin was removed by immersing the slides twice for 5 min in fresh xylene. The tissue was rehydrated by passing it through a series of graded ethanol concentrations: 100, 100, 95, 95, 70 followed by PBS twice for 5 min. After treating the sections with 0.2 M HCL for 20 min and washing them twice for 5 min in PBS, tissue was treated with proteinase K (50 g/ml) at 37°C for 30 min to improve the penetration of the probe. Following washing in PBS (twice for 5 min), sections were placed in 4% paraformaldehyde for 20 min to stop residual proteinase K and RNAse activity. Tissues were washed twice for 5 min in PBS and acetylated in acetic anhydride (0.2% in 100 mm triethanolamine) in order to reduce the electrostatic binding of the probe to the section by acetylating positively charged amino groups. Sections were dehydrated through a series of graded ethanol steps (PBS, 70% ethanol, 95%, 95%, 100% and 100%) and air-dried before applying the probe. m NaH 2 PO 4 , 10% dextran sulphate and transfer RNA 1 g/ml (Sigma Chemical Co, St Louis, USA). To ensure a uniform solution, the mixture was heated at 80°C for 3 mins and cooled on ice. The probe was applied, and the slides were incubated at 42°C overnight. High-stringency washes were performed in a hybridization solution at 50 C twice for 1 h. The sections were then washed in NTE (NaCl 0.5 m, Tris pH7.2 10 mm, EDTA 1 mm) at 37°C for 30 min before treating them with RNAse A, 20 g/ml (Pharmacia, Uppsala, Sweden) in NTE at 37°C to remove the unbound probe. To remove the RNAse, two subsequent washes in NTE at 37°C were performed and the sections were washed in 0.1 × SSc for 30 min.
Detection of digoxigenin-labelled probes:
After a brief wash in buffer 1 (0.1 mol/l maleic acid in 0.15 mol/l NaCl, pH 7.5), sections were incubated at room temperature for 30 min in buffer 2 (blocking stock solution 1:10 in buffer 1). Anti-digoxigenin antibody conjugate (anti-digoxigenin-AP Fab fragments: Boehringer, Mannheim Gmbh, Mannheim, Germany) 1:5000 in buffer 2 was applied for 15 min at room temperature. Sections were equilibrated in buffer 3 (Tris-HCL 100 mmol/l, NaCl 100 mmol/l and MgCl 2 50 mmol/l, pH 9.5) for 2 min before applying the colour substrate: 33.8 l 4-nitro-blue tetrazolium chloride (NTE) (Boehringer Meinheim) and 35 l 5-bromo-4-chhloro-3-indolyl-phosphate (x-phosphate) (Boehringer Mannheim) in 10 ml buffer 3. Slides were incubated overnight in the dark and at room temperature. Excess colour substrate was removed by washing in buffer 4 (Tris-HCL, 10 mMol; EDTA 1 mMol, pH 8.0) and rinsing in tap water. Sections were counterstained in Kernechtrof solution (0.2 g nuclear fast red and 10 g aluminium sulphate in 200 ml distilled water) 37 overnight, then washed in tap water and air-dried. After immersion in xylene, the slides were mounted using Histoclad (Clay Adams, Parsippany, NJ, USA).
IFN␥ quantification
IFN␥ contents were measured in tissue sonicates 38 from the inflamed colons after 6 days of DSS ingestion. Two centimeters of the distal end of the rectum were taken, thoroughly washed and placed in 600 l of serum-free RPMI 1640. Samples were stored at −70°C until assay. Tissues were thawed, minced and sonicated for 60 sec and centrifuged for 10 min at 3200 rpm. Supernatants were collected, blinded and assayed for IFN␥ contents by ELISA. Briefly, IFN␥ was measured on commercial ELISA plates (R&D Systems, USA) pre-coated with monoclonal anti-mIFN␥ according to manufacturer's instructions. Sensitivity of the assay was less than 2 pg/ml.
Statistical analysis
Disease activity index was derived by using correlation coefficient to correlate clinical signs with the histological score as previously described in detail. 13 Disease activity index and IFN␥ levels in tissues of the IL-4 deficient mice and the wild-type strain were compared by using unpaired, two-tailed Student's t-test. P values of below 0.05 were considered to be significant. Histological scores were compared by using Mann-Whitney U test for nonparametric data.
